| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Syncytial Virus, Human | 2 | 2025 | 233 | 0.920 |
Why?
|
| Genome, Viral | 1 | 2025 | 179 | 0.870 |
Why?
|
| Respiratory Syncytial Virus Infections | 2 | 2025 | 377 | 0.850 |
Why?
|
| Genome, Insect | 6 | 2020 | 109 | 0.820 |
Why?
|
| Caliciviridae Infections | 1 | 2025 | 361 | 0.730 |
Why?
|
| Evolution, Molecular | 10 | 2020 | 700 | 0.710 |
Why?
|
| Norovirus | 1 | 2025 | 350 | 0.700 |
Why?
|
| Lignin | 6 | 2013 | 18 | 0.670 |
Why?
|
| Phanerochaete | 4 | 2010 | 4 | 0.640 |
Why?
|
| Cytochrome P-450 Enzyme System | 4 | 2010 | 115 | 0.600 |
Why?
|
| Genomics | 13 | 2025 | 1652 | 0.590 |
Why?
|
| Phylogeny | 13 | 2025 | 763 | 0.560 |
Why?
|
| Genome, Fungal | 6 | 2013 | 34 | 0.550 |
Why?
|
| Mutation | 15 | 2025 | 6250 | 0.510 |
Why?
|
| Agaricus | 2 | 2013 | 2 | 0.510 |
Why?
|
| Sequence Analysis, DNA | 8 | 2021 | 1803 | 0.480 |
Why?
|
| High-Throughput Nucleotide Sequencing | 9 | 2022 | 946 | 0.460 |
Why?
|
| Insect Proteins | 4 | 2020 | 111 | 0.450 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2013 | 198 | 0.440 |
Why?
|
| Genome | 6 | 2022 | 504 | 0.430 |
Why?
|
| Oxidoreductases | 2 | 2013 | 101 | 0.410 |
Why?
|
| Biomarkers, Tumor | 4 | 2025 | 1683 | 0.410 |
Why?
|
| Proteogenomics | 2 | 2025 | 110 | 0.380 |
Why?
|
| Genetic Variation | 5 | 2021 | 1580 | 0.380 |
Why?
|
| Gene Duplication | 4 | 2017 | 370 | 0.360 |
Why?
|
| Whole Genome Sequencing | 4 | 2022 | 327 | 0.360 |
Why?
|
| Germ-Line Mutation | 3 | 2020 | 368 | 0.350 |
Why?
|
| Transcriptome | 6 | 2022 | 1125 | 0.350 |
Why?
|
| Biological Evolution | 4 | 2023 | 243 | 0.350 |
Why?
|
| Pharmacogenetics | 2 | 2022 | 200 | 0.320 |
Why?
|
| Mixed Function Oxygenases | 2 | 2010 | 36 | 0.320 |
Why?
|
| Insecticide Resistance | 3 | 2020 | 37 | 0.310 |
Why?
|
| Host-Parasite Interactions | 3 | 2020 | 82 | 0.310 |
Why?
|
| Heteroptera | 2 | 2020 | 17 | 0.310 |
Why?
|
| Repressor Proteins | 4 | 2019 | 813 | 0.300 |
Why?
|
| Arthropods | 2 | 2020 | 30 | 0.290 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2025 | 816 | 0.290 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2021 | 215 | 0.270 |
Why?
|
| Xylella | 1 | 2006 | 1 | 0.260 |
Why?
|
| Plants | 1 | 2006 | 47 | 0.250 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2019 | 1304 | 0.240 |
Why?
|
| Gene Regulatory Networks | 2 | 2020 | 386 | 0.240 |
Why?
|
| Multigene Family | 5 | 2020 | 305 | 0.240 |
Why?
|
| Oligonucleotide Probes | 1 | 2025 | 89 | 0.230 |
Why?
|
| Xenobiotics | 1 | 2005 | 28 | 0.230 |
Why?
|
| Genome, Bacterial | 1 | 2006 | 213 | 0.230 |
Why?
|
| Gene Transfer, Horizontal | 4 | 2020 | 51 | 0.230 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 628 | 0.220 |
Why?
|
| Organ Specificity | 1 | 2025 | 412 | 0.220 |
Why?
|
| Animals | 26 | 2023 | 34850 | 0.220 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 246 | 0.210 |
Why?
|
| Species Specificity | 5 | 2023 | 542 | 0.210 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2018 | 333 | 0.210 |
Why?
|
| Genetic Speciation | 2 | 2020 | 28 | 0.210 |
Why?
|
| Gene Flow | 1 | 2023 | 15 | 0.210 |
Why?
|
| Mosaicism | 1 | 2025 | 250 | 0.200 |
Why?
|
| Papio | 1 | 2023 | 60 | 0.200 |
Why?
|
| Humans | 43 | 2025 | 132247 | 0.200 |
Why?
|
| Viral Load | 1 | 2025 | 408 | 0.200 |
Why?
|
| Gastroenteritis | 1 | 2025 | 365 | 0.190 |
Why?
|
| Chromosomes, Mammalian | 1 | 2022 | 43 | 0.190 |
Why?
|
| Mesocricetus | 1 | 2022 | 74 | 0.190 |
Why?
|
| Cell Proliferation | 3 | 2021 | 2511 | 0.190 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2021 | 998 | 0.190 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2022 | 34 | 0.190 |
Why?
|
| Herpesvirus 3, Equid | 1 | 2021 | 4 | 0.180 |
Why?
|
| Hemorrhagic Disorders | 1 | 2021 | 22 | 0.180 |
Why?
|
| Genotype | 2 | 2025 | 2703 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2020 | 3358 | 0.180 |
Why?
|
| Receptor, ErbB-2 | 1 | 2025 | 549 | 0.180 |
Why?
|
| Receptors, Odorant | 2 | 2020 | 39 | 0.180 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2015 | 613 | 0.180 |
Why?
|
| Pest Control, Biological | 2 | 2018 | 18 | 0.180 |
Why?
|
| Databases, Genetic | 3 | 2016 | 502 | 0.180 |
Why?
|
| Kidney Neoplasms | 2 | 2015 | 451 | 0.180 |
Why?
|
| Transplants | 1 | 2021 | 36 | 0.170 |
Why?
|
| Elephants | 1 | 2021 | 44 | 0.170 |
Why?
|
| Life History Traits | 1 | 2020 | 6 | 0.170 |
Why?
|
| Fungal Proteins | 2 | 2013 | 135 | 0.170 |
Why?
|
| Thysanoptera | 1 | 2020 | 6 | 0.170 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2020 | 20 | 0.170 |
Why?
|
| Breast Neoplasms | 2 | 2025 | 2681 | 0.170 |
Why?
|
| Adaptation, Physiological | 3 | 2018 | 272 | 0.170 |
Why?
|
| Mutation Accumulation | 1 | 2020 | 2 | 0.170 |
Why?
|
| Hymenoptera | 1 | 2020 | 8 | 0.170 |
Why?
|
| GTP Phosphohydrolases | 2 | 2019 | 156 | 0.160 |
Why?
|
| Social Skills | 1 | 2020 | 16 | 0.160 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2020 | 2851 | 0.160 |
Why?
|
| Paternal Age | 1 | 2020 | 17 | 0.160 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2021 | 265 | 0.160 |
Why?
|
| Male | 25 | 2025 | 65012 | 0.160 |
Why?
|
| Social Behavior | 2 | 2020 | 225 | 0.160 |
Why?
|
| Female | 26 | 2025 | 70785 | 0.160 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2021 | 234 | 0.160 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2019 | 33 | 0.160 |
Why?
|
| Esophageal Neoplasms | 1 | 2024 | 386 | 0.160 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2019 | 770 | 0.160 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 2442 | 0.150 |
Why?
|
| Neurofibromin 1 | 1 | 2019 | 50 | 0.150 |
Why?
|
| DNA Methylation | 3 | 2021 | 1122 | 0.150 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2018 | 810 | 0.150 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 274 | 0.150 |
Why?
|
| Hemiptera | 1 | 2019 | 18 | 0.150 |
Why?
|
| Genetic Loci | 1 | 2020 | 360 | 0.150 |
Why?
|
| DNA, Neoplasm | 2 | 2018 | 295 | 0.150 |
Why?
|
| Organ Transplantation | 1 | 2021 | 180 | 0.150 |
Why?
|
| Clinical Protocols | 1 | 2020 | 239 | 0.150 |
Why?
|
| Insecticides | 2 | 2016 | 62 | 0.150 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2018 | 118 | 0.150 |
Why?
|
| Genetic Markers | 1 | 2020 | 618 | 0.140 |
Why?
|
| Amphipoda | 1 | 2018 | 5 | 0.140 |
Why?
|
| Wasps | 1 | 2018 | 14 | 0.140 |
Why?
|
| Amino Acid Sequence | 4 | 2020 | 2669 | 0.140 |
Why?
|
| Paraffin Embedding | 1 | 2018 | 41 | 0.140 |
Why?
|
| Nucleic Acids | 1 | 2018 | 25 | 0.140 |
Why?
|
| Heterotaxy Syndrome | 1 | 2019 | 63 | 0.140 |
Why?
|
| Blattellidae | 1 | 2018 | 6 | 0.140 |
Why?
|
| Isoptera | 1 | 2018 | 6 | 0.140 |
Why?
|
| Estrogen Receptor alpha | 1 | 2021 | 439 | 0.140 |
Why?
|
| Cytochrome P-450 CYP2A6 | 1 | 2018 | 11 | 0.140 |
Why?
|
| Cluster Analysis | 4 | 2018 | 431 | 0.140 |
Why?
|
| Zebrafish Proteins | 1 | 2019 | 129 | 0.140 |
Why?
|
| Spiders | 1 | 2017 | 7 | 0.140 |
Why?
|
| Meningioma | 1 | 2019 | 141 | 0.140 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2020 | 240 | 0.140 |
Why?
|
| Water Pollutants, Chemical | 1 | 2018 | 41 | 0.140 |
Why?
|
| Skin Neoplasms | 2 | 2015 | 897 | 0.140 |
Why?
|
| Forecasting | 1 | 2019 | 373 | 0.130 |
Why?
|
| Prognosis | 7 | 2021 | 5016 | 0.130 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 1541 | 0.130 |
Why?
|
| Behavior, Animal | 1 | 2020 | 506 | 0.130 |
Why?
|
| Feeding Behavior | 3 | 2020 | 721 | 0.130 |
Why?
|
| Evidence-Based Practice | 1 | 2018 | 115 | 0.130 |
Why?
|
| Meningeal Neoplasms | 1 | 2019 | 216 | 0.130 |
Why?
|
| Computational Biology | 3 | 2014 | 876 | 0.130 |
Why?
|
| Nicotine | 1 | 2018 | 118 | 0.130 |
Why?
|
| Coleoptera | 1 | 2016 | 14 | 0.130 |
Why?
|
| Ceratitis capitata | 1 | 2016 | 5 | 0.130 |
Why?
|
| Gene Expression Profiling | 5 | 2019 | 1883 | 0.130 |
Why?
|
| Small Molecule Libraries | 1 | 2018 | 135 | 0.130 |
Why?
|
| Brain Neoplasms | 2 | 2018 | 1410 | 0.130 |
Why?
|
| Adenocarcinoma | 1 | 2024 | 1018 | 0.130 |
Why?
|
| Software | 1 | 2021 | 731 | 0.130 |
Why?
|
| Genome, Human | 3 | 2021 | 1331 | 0.130 |
Why?
|
| Coculture Techniques | 1 | 2017 | 238 | 0.130 |
Why?
|
| Molecular Sequence Data | 5 | 2012 | 3771 | 0.120 |
Why?
|
| Metabolome | 1 | 2019 | 324 | 0.120 |
Why?
|
| Ectoparasitic Infestations | 1 | 2016 | 8 | 0.120 |
Why?
|
| Bedbugs | 1 | 2016 | 8 | 0.120 |
Why?
|
| Death, Sudden | 1 | 2016 | 48 | 0.120 |
Why?
|
| Sezary Syndrome | 1 | 2015 | 14 | 0.120 |
Why?
|
| Molecular Sequence Annotation | 1 | 2016 | 157 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2015 | 29 | 0.120 |
Why?
|
| Sarcoma, Clear Cell | 1 | 2015 | 21 | 0.120 |
Why?
|
| Diptera | 1 | 2015 | 27 | 0.120 |
Why?
|
| Carcinoma, Papillary | 1 | 2015 | 94 | 0.110 |
Why?
|
| Biodiversity | 1 | 2015 | 87 | 0.110 |
Why?
|
| Clonal Evolution | 1 | 2015 | 49 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 2062 | 0.110 |
Why?
|
| Cyclin B | 1 | 2014 | 23 | 0.110 |
Why?
|
| Autism Spectrum Disorder | 1 | 2020 | 430 | 0.110 |
Why?
|
| Oncogene Fusion | 1 | 2014 | 26 | 0.110 |
Why?
|
| Exonucleases | 1 | 2014 | 24 | 0.110 |
Why?
|
| DNA Copy Number Variations | 5 | 2019 | 1034 | 0.110 |
Why?
|
| DNA Polymerase II | 1 | 2014 | 20 | 0.110 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2014 | 44 | 0.110 |
Why?
|
| Chromosomes | 1 | 2014 | 139 | 0.110 |
Why?
|
| Phenotype | 5 | 2025 | 4540 | 0.110 |
Why?
|
| Introduced Species | 3 | 2020 | 26 | 0.110 |
Why?
|
| Disease Progression | 5 | 2020 | 2233 | 0.100 |
Why?
|
| Glioma | 1 | 2018 | 535 | 0.100 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2014 | 97 | 0.100 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 146 | 0.100 |
Why?
|
| Biotransformation | 1 | 2013 | 56 | 0.100 |
Why?
|
| Snails | 1 | 2012 | 2 | 0.100 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2014 | 127 | 0.100 |
Why?
|
| Mutation, Missense | 2 | 2014 | 937 | 0.100 |
Why?
|
| Ecology | 1 | 2012 | 16 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2015 | 2680 | 0.100 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2014 | 222 | 0.100 |
Why?
|
| Genome-Wide Association Study | 5 | 2020 | 1831 | 0.100 |
Why?
|
| DNA Replication | 1 | 2014 | 353 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 815 | 0.100 |
Why?
|
| Epithelial Cells | 1 | 2017 | 906 | 0.100 |
Why?
|
| Basidiomycota | 1 | 2012 | 12 | 0.090 |
Why?
|
| Adult | 11 | 2025 | 31614 | 0.090 |
Why?
|
| Sarcoma | 1 | 2014 | 207 | 0.090 |
Why?
|
| Neoadjuvant Therapy | 2 | 2025 | 400 | 0.090 |
Why?
|
| DNA Mutational Analysis | 3 | 2021 | 826 | 0.090 |
Why?
|
| Cardiomyopathies | 1 | 2016 | 509 | 0.090 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2014 | 241 | 0.090 |
Why?
|
| Exome | 4 | 2018 | 1087 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 1829 | 0.090 |
Why?
|
| Clone Cells | 2 | 2025 | 179 | 0.080 |
Why?
|
| Lung | 3 | 2025 | 1556 | 0.080 |
Why?
|
| Cell Line, Tumor | 4 | 2019 | 3691 | 0.080 |
Why?
|
| A549 Cells | 2 | 2022 | 49 | 0.080 |
Why?
|
| Drosophila | 1 | 2014 | 824 | 0.080 |
Why?
|
| Genetic Association Studies | 3 | 2019 | 857 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 728 | 0.080 |
Why?
|
| Genetic Testing | 1 | 2016 | 1099 | 0.080 |
Why?
|
| Middle Aged | 8 | 2025 | 29021 | 0.080 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 1 | 2010 | 77 | 0.080 |
Why?
|
| Polyporales | 1 | 2009 | 1 | 0.080 |
Why?
|
| Culture Media | 2 | 2010 | 182 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 764 | 0.070 |
Why?
|
| DNA, Complementary | 2 | 2010 | 454 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 768 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 3995 | 0.070 |
Why?
|
| Base Sequence | 3 | 2022 | 2900 | 0.070 |
Why?
|
| Cloning, Molecular | 2 | 2010 | 811 | 0.070 |
Why?
|
| Cell Differentiation | 1 | 2015 | 1965 | 0.070 |
Why?
|
| Gene Dosage | 2 | 2020 | 449 | 0.070 |
Why?
|
| Child | 9 | 2020 | 25783 | 0.070 |
Why?
|
| Neoplasms | 2 | 2020 | 2961 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 2 | 2021 | 1045 | 0.070 |
Why?
|
| Biopsy | 2 | 2021 | 1288 | 0.070 |
Why?
|
| Heart Defects, Congenital | 1 | 2019 | 1866 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 1757 | 0.060 |
Why?
|
| Plant Diseases | 1 | 2006 | 26 | 0.060 |
Why?
|
| Fimbriae, Bacterial | 1 | 2006 | 44 | 0.060 |
Why?
|
| Young Adult | 5 | 2021 | 9966 | 0.060 |
Why?
|
| Gene Library | 2 | 2018 | 213 | 0.060 |
Why?
|
| Genes, Bacterial | 1 | 2006 | 217 | 0.060 |
Why?
|
| Cell Line | 2 | 2022 | 2724 | 0.060 |
Why?
|
| Oxidation-Reduction | 3 | 2012 | 436 | 0.060 |
Why?
|
| Hydrocarbons, Aromatic | 1 | 2005 | 5 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 1381 | 0.060 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2018 | 394 | 0.060 |
Why?
|
| Enzyme Induction | 1 | 2005 | 97 | 0.060 |
Why?
|
| Larva | 2 | 2016 | 260 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2018 | 3414 | 0.060 |
Why?
|
| Reproduction | 2 | 2020 | 226 | 0.060 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2005 | 55 | 0.060 |
Why?
|
| Trastuzumab | 1 | 2025 | 154 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2006 | 1008 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2005 | 651 | 0.050 |
Why?
|
| Escherichia coli | 2 | 2010 | 995 | 0.050 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2025 | 241 | 0.050 |
Why?
|
| Survival Rate | 2 | 2021 | 2196 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 7138 | 0.050 |
Why?
|
| X-ray Repair Cross Complementing Protein 1 | 1 | 2022 | 20 | 0.050 |
Why?
|
| Aged | 5 | 2020 | 21482 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2005 | 364 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 2 | 2015 | 409 | 0.050 |
Why?
|
| Carboplatin | 1 | 2022 | 85 | 0.050 |
Why?
|
| Host-Pathogen Interactions | 1 | 2025 | 263 | 0.050 |
Why?
|
| Infant | 4 | 2020 | 13049 | 0.050 |
Why?
|
| Models, Genetic | 1 | 2005 | 771 | 0.050 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2022 | 46 | 0.050 |
Why?
|
| Child, Preschool | 4 | 2020 | 14736 | 0.050 |
Why?
|
| Animals, Zoo | 1 | 2021 | 17 | 0.050 |
Why?
|
| Oxygen | 1 | 2005 | 569 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2023 | 328 | 0.040 |
Why?
|
| Age Factors | 2 | 2020 | 2923 | 0.040 |
Why?
|
| Serologic Tests | 1 | 2021 | 130 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2021 | 92 | 0.040 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2020 | 5 | 0.040 |
Why?
|
| Food Chain | 1 | 2020 | 11 | 0.040 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2020 | 19 | 0.040 |
Why?
|
| Crops, Agricultural | 1 | 2020 | 16 | 0.040 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2020 | 21 | 0.040 |
Why?
|
| Herbivory | 1 | 2020 | 11 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1500 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2020 | 5176 | 0.040 |
Why?
|
| Genome Size | 1 | 2020 | 17 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2022 | 333 | 0.040 |
Why?
|
| Mutation Rate | 1 | 2020 | 72 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2021 | 755 | 0.040 |
Why?
|
| Haplotypes | 1 | 2021 | 545 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2020 | 296 | 0.040 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2021 | 239 | 0.040 |
Why?
|
| Transplant Recipients | 1 | 2021 | 225 | 0.040 |
Why?
|
| Immunity | 1 | 2020 | 183 | 0.040 |
Why?
|
| Adolescent | 4 | 2021 | 20557 | 0.040 |
Why?
|
| CYS2-HIS2 Zinc Fingers | 1 | 2019 | 6 | 0.040 |
Why?
|
| DNA Transposable Elements | 1 | 2020 | 188 | 0.040 |
Why?
|
| Ecosystem | 1 | 2020 | 107 | 0.040 |
Why?
|
| Vision, Ocular | 1 | 2020 | 132 | 0.040 |
Why?
|
| United States | 3 | 2022 | 11669 | 0.040 |
Why?
|
| Pigmentation | 1 | 2019 | 36 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2020 | 333 | 0.040 |
Why?
|
| Peroxidases | 1 | 2019 | 29 | 0.040 |
Why?
|
| Perception | 1 | 2020 | 236 | 0.040 |
Why?
|
| Genes, Homeobox | 1 | 2019 | 72 | 0.040 |
Why?
|
| Firmicutes | 1 | 2018 | 22 | 0.040 |
Why?
|
| Pets | 1 | 2018 | 18 | 0.040 |
Why?
|
| Macaca mulatta | 1 | 2020 | 506 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2015 | 4720 | 0.040 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2018 | 34 | 0.040 |
Why?
|
| Ecotoxicology | 1 | 2018 | 3 | 0.040 |
Why?
|
| Sarcoma, Ewing | 1 | 2019 | 116 | 0.040 |
Why?
|
| Cytochrome P450 Family 4 | 1 | 2018 | 5 | 0.040 |
Why?
|
| Body Patterning | 1 | 2019 | 130 | 0.040 |
Why?
|
| Virus Replication | 1 | 2022 | 636 | 0.040 |
Why?
|
| Geologic Sediments | 1 | 2018 | 8 | 0.040 |
Why?
|
| Proteomics | 1 | 2022 | 596 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2018 | 105 | 0.040 |
Why?
|
| Receptor, Notch2 | 1 | 2018 | 12 | 0.040 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2018 | 22 | 0.040 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2018 | 35 | 0.040 |
Why?
|
| Moths | 1 | 2018 | 23 | 0.040 |
Why?
|
| Wilms Tumor | 1 | 2019 | 119 | 0.040 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2018 | 18 | 0.040 |
Why?
|
| Toxicity Tests | 1 | 2018 | 35 | 0.040 |
Why?
|
| Bifidobacterium | 1 | 2018 | 68 | 0.040 |
Why?
|
| Aging | 1 | 2025 | 1254 | 0.030 |
Why?
|
| Multifactorial Inheritance | 1 | 2019 | 167 | 0.030 |
Why?
|
| Tissue Banks | 1 | 2018 | 30 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2020 | 377 | 0.030 |
Why?
|
| Mice | 3 | 2021 | 18507 | 0.030 |
Why?
|
| Smell | 1 | 2019 | 131 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2021 | 503 | 0.030 |
Why?
|
| Crustacea | 1 | 2017 | 7 | 0.030 |
Why?
|
| Copepoda | 1 | 2017 | 9 | 0.030 |
Why?
|
| Chemoreceptor Cells | 1 | 2017 | 15 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2020 | 413 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 579 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2018 | 106 | 0.030 |
Why?
|
| Siblings | 1 | 2018 | 202 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2020 | 821 | 0.030 |
Why?
|
| Synteny | 1 | 2017 | 78 | 0.030 |
Why?
|
| North America | 1 | 2018 | 265 | 0.030 |
Why?
|
| Insecta | 1 | 2017 | 64 | 0.030 |
Why?
|
| Databases, Nucleic Acid | 1 | 2017 | 73 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2019 | 607 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 4690 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2019 | 215 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2018 | 317 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 174 | 0.030 |
Why?
|
| Trees | 1 | 2016 | 21 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2020 | 1574 | 0.030 |
Why?
|
| Osteosarcoma | 1 | 2019 | 263 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2018 | 233 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2018 | 174 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2010 | 1350 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 258 | 0.030 |
Why?
|
| Rhabdomyosarcoma | 1 | 2019 | 215 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2020 | 360 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2018 | 862 | 0.030 |
Why?
|
| Diagnosis | 1 | 2016 | 30 | 0.030 |
Why?
|
| Respiratory Mucosa | 1 | 2017 | 96 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2019 | 1096 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2022 | 823 | 0.030 |
Why?
|
| RNA Interference | 1 | 2018 | 515 | 0.030 |
Why?
|
| Autopsy | 1 | 2016 | 120 | 0.030 |
Why?
|
| Zebrafish | 1 | 2019 | 421 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2018 | 750 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 689 | 0.030 |
Why?
|
| Genetic Drift | 1 | 2015 | 23 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 689 | 0.030 |
Why?
|
| Tandem Repeat Sequences | 1 | 2015 | 36 | 0.030 |
Why?
|
| Access to Information | 1 | 2016 | 45 | 0.030 |
Why?
|
| Recurrence | 1 | 2019 | 1453 | 0.030 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2015 | 18 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2016 | 55 | 0.030 |
Why?
|
| Milk, Human | 1 | 2018 | 308 | 0.030 |
Why?
|
| Heterografts | 1 | 2016 | 199 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 2015 | 136 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2016 | 341 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 384 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 755 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2018 | 387 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 302 | 0.030 |
Why?
|
| 5'-Nucleotidase | 1 | 2015 | 21 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 1348 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 1204 | 0.030 |
Why?
|
| Ikaros Transcription Factor | 1 | 2015 | 32 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 152 | 0.030 |
Why?
|
| CREB-Binding Protein | 1 | 2015 | 58 | 0.030 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2014 | 8 | 0.030 |
Why?
|
| Replication Origin | 1 | 2014 | 12 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 1161 | 0.030 |
Why?
|
| Microsatellite Instability | 1 | 2014 | 40 | 0.030 |
Why?
|
| Codon | 1 | 2014 | 98 | 0.030 |
Why?
|
| Apoptosis | 1 | 2021 | 1901 | 0.030 |
Why?
|
| RNA | 1 | 2018 | 552 | 0.030 |
Why?
|
| DNA Polymerase III | 1 | 2014 | 28 | 0.030 |
Why?
|
| Erdheim-Chester Disease | 1 | 2014 | 28 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2014 | 33 | 0.030 |
Why?
|
| CpG Islands | 1 | 2015 | 343 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2015 | 152 | 0.030 |
Why?
|
| Metagenome | 1 | 2015 | 146 | 0.030 |
Why?
|
| Workflow | 1 | 2015 | 134 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2019 | 550 | 0.030 |
Why?
|
| Xanthogranuloma, Juvenile | 1 | 2014 | 34 | 0.030 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2014 | 100 | 0.030 |
Why?
|
| Histiocytosis, Sinus | 1 | 2014 | 34 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2014 | 64 | 0.030 |
Why?
|
| Japan | 1 | 2014 | 156 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 165 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2014 | 144 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 2014 | 164 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2016 | 200 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2022 | 3093 | 0.030 |
Why?
|
| ras Proteins | 1 | 2014 | 146 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2015 | 686 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2019 | 1402 | 0.030 |
Why?
|
| Reproduction, Asexual | 1 | 2012 | 2 | 0.030 |
Why?
|
| Gene Rearrangement | 1 | 2015 | 328 | 0.030 |
Why?
|
| Expressed Sequence Tags | 1 | 2012 | 81 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2014 | 441 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 1285 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 309 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 343 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2019 | 1700 | 0.020 |
Why?
|
| DNA | 1 | 2018 | 1479 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2015 | 590 | 0.020 |
Why?
|
| Microsatellite Repeats | 1 | 2012 | 236 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2012 | 158 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 799 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 1718 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 446 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2014 | 448 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 5410 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2014 | 1120 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 3046 | 0.020 |
Why?
|
| Biodegradation, Environmental | 1 | 2010 | 13 | 0.020 |
Why?
|
| Pichia | 1 | 2010 | 56 | 0.020 |
Why?
|
| Cytochromes b5 | 1 | 2010 | 3 | 0.020 |
Why?
|
| Cytochrome-B(5) Reductase | 1 | 2010 | 4 | 0.020 |
Why?
|
| Liver | 1 | 2018 | 1797 | 0.020 |
Why?
|
| NADPH-Ferrihemoprotein Reductase | 1 | 2010 | 4 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2018 | 861 | 0.020 |
Why?
|
| Catalysis | 1 | 2010 | 139 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2010 | 301 | 0.020 |
Why?
|
| Nitrogen | 1 | 2010 | 124 | 0.020 |
Why?
|
| Carbon | 1 | 2010 | 94 | 0.020 |
Why?
|
| Cellulases | 1 | 2009 | 2 | 0.020 |
Why?
|
| Environmental Pollutants | 1 | 2010 | 78 | 0.020 |
Why?
|
| Wood | 1 | 2009 | 9 | 0.020 |
Why?
|
| Glycoside Hydrolases | 1 | 2009 | 17 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2019 | 2491 | 0.020 |
Why?
|
| Enzymes | 1 | 2009 | 44 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2015 | 916 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 6451 | 0.020 |
Why?
|
| Risk Factors | 1 | 2022 | 10945 | 0.020 |
Why?
|
| Pregnancy | 1 | 2020 | 7557 | 0.020 |
Why?
|
| Texas | 1 | 2016 | 3632 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2015 | 1597 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 3018 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2010 | 416 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 984 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 1555 | 0.020 |
Why?
|
| Gene Expression | 1 | 2010 | 1563 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 1423 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 13027 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2016 | 8548 | 0.010 |
Why?
|